BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3633631)

  • 21. Effect of exogenous pancreatic enzymes on gastrointestinal and pancreatic hormone release and gastrointestinal motility.
    Malfertheiner P; Domínguez-Muñoz JE
    Digestion; 1993; 54 Suppl 2():15-20. PubMed ID: 8224568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind cross-over trial of an enzyme preparation in pancreatic steatorrhoea.
    Balakrishnan V; Hareendran A; Nair CS
    J Assoc Physicians India; 1981 Mar; 29(3):207-9. PubMed ID: 6912244
    [No Abstract]   [Full Text] [Related]  

  • 24. Pancreatic enzyme therapy in childhood celiac disease. A double-blind prospective randomized study.
    Carroccio A; Iacono G; Montalto G; Cavataio F; Lorello D; Greco L; Soresi M; Notarbartolo A
    Dig Dis Sci; 1995 Dec; 40(12):2555-60. PubMed ID: 8536512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Requirements for successful pancreatic enzyme replacement therapy (comparative study of Kreon and Panpur)].
    Pap A; Korom M; Marosi E; Varró V
    Orv Hetil; 1990 Feb; 131(5):241-4. PubMed ID: 2304764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of pancreatic insufficiency with a preparation containing high lipase activity].
    Pap A; Szilágyi V; Marosi E
    Orv Hetil; 1997 Mar; 138(10):601-4. PubMed ID: 9157336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial.
    Mössner J; Secknus R; Meyer J; Niederau C; Adler G
    Digestion; 1992; 53(1-2):54-66. PubMed ID: 1289173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea.
    Malesci A; Mariani A; Mezzi G; Bocchia P; Basilico M
    J Clin Gastroenterol; 1994 Jan; 18(1):32-5. PubMed ID: 8113582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the substitution therapy with pancreatic enzyme preparations].
    Goebell H; Bode C
    Med Welt; 1969 Apr; 20(15):877-84. PubMed ID: 5784374
    [No Abstract]   [Full Text] [Related]  

  • 30. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L; Rodríguez R; Guarner F; Malagelada JR
    Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benefit of pancreatic enzyme substitution after total gastrectomy.
    Armbrecht U; Lundell L; Stockbrügger RW
    Aliment Pharmacol Ther; 1988 Dec; 2(6):493-500. PubMed ID: 2979271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring the effect of substitution therapy in patients with exocrine pancreatic insufficiency.
    Jørgensen BB; Pedersen NT; Worning H
    Scand J Gastroenterol; 1991 Mar; 26(3):321-6. PubMed ID: 1853155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Critical study of the therapeutic substitution by digestive enzymes].
    Conte M; Fouet P
    Gastroenterologia; 1966; 105():Suppl:30-42. PubMed ID: 5328826
    [No Abstract]   [Full Text] [Related]  

  • 34. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
    Griffin SM; Alderson D; Farndon JR
    Gut; 1989 Jul; 30(7):1012-5. PubMed ID: 2759481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pancreatic digestive enzymes, sodium bicarbonate, and a proton pump inhibitor on steatorrhoea caused by pancreatic diseases.
    Nakamura T; Takebe K; Kudoh K; Ishii M; Imamura K; Kikuchi H; Kasai F; Tandoh Y; Yamada N; Arai Y
    J Int Med Res; 1995; 23(1):37-47. PubMed ID: 7774757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
    Stead RJ; Skypala I; Hodson ME; Batten JC
    Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of a synthetic prostaglandin E1 analogue (misoprostol) as an adjunct to pancreatic enzyme replacement in cystic fibrosis.
    Cleghorn GJ; Shepherd RW; Holt TL
    Scand J Gastroenterol Suppl; 1988; 143():142-7. PubMed ID: 3133753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
    Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin E production in chronic pancreatitis.
    Raithel M; Dormann H; Harsch IA; Winterkamp S; Weidenhiller M; Fischer B; Hahn EG; Schneider T
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):801-7. PubMed ID: 12811311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.